Aptar today announced a partnership with ŌURA to integrate Aptar’s Migraine Buddy® with Oura Ring. Migraine Buddy, a leading migraine tracking app with millions of users, will connect with the continuous biometric data from Oura Ring, with the goal of providing individuals with personalized insights into their migraine patterns and potential triggers.
Migraine Buddy is designed to empower people suffering from headaches and migraine through data-driven insights. Its user-friendly design and robust tracking capabilities have quickly garnered widespread popularity, making it a top-choice mobile application. By integrating Migraine Buddy’s detailed symptom tracking, reporting, and coaching capabilities, with continuous biometric data from Oura Ring, including sleep, heart rate variability, temperature trends, cycle insights, and more, users may be able to gain visibility into potential migraine triggers and related physiological patterns.
While the combined solution is designed for everyone, it is especially valuable for women, who experience migraines more frequently due to hormonal fluctuations. With the majority of Migraine Buddy users being women, the ability to connect Oura Ring to migraine data may help enlighten how hormonal shifts influence symptoms and support a deeper understanding of overall health.
Migraine is a neurological disorder characterized by recurring headaches of moderate to severe intensity, often accompanied by nausea, sensitivity to light, and other symptoms. It affects approximately 12% of the global population1, disproportionately impacting women due to hormonal factors. According to the World Health Organization, migraines are responsible for high population levels of disability and ill health2.
“This partnership is about empowering our users with seamless and fully automated tracking tools to more deeply understand what could impact their migraine episodes,” said Aurore Beaume, Chief Business Officer, Aptar Digital Health. “Bringing our insights together aims to create an even more holistic experience that can help people recognize patterns and make choices to enhance their health.”
“Our collaboration with ŌURA reflects Aptar’s commitment to drive innovation across the entire journey from formulation to patients,” said Gael Touya, President, Aptar Pharma. “Connecting Migraine Buddy with Oura Ring brings Aptar Pharma closer to the future management of health where data empowers every patient to anticipate and better manage their conditions.”
“At ŌURA, we’re committed to ensuring that continuous biometric insights play a meaningful role in how people understand and manage their health,” said Dorothy Kilroy, Chief Commercial Officer at ŌURA. “This is especially true for women, whose experiences—including migraines—are often shaped by hormonal shifts. As a company deeply invested in advancing women’s health, our partnership with Aptar Digital Health builds on that mission, bringing together Oura’s real-time signals with Migraine Buddy’s rich tracking experience to give individuals a clearer, more actionable view of their migraine patterns. It’s a powerful step toward a future where migraine care is more proactive and grounded in each person’s unique physiology.”
